A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...

A tiny molecule called a nanobody may succeed where today's cancer drugs often fail, according to University of Hawaiʻi at ...

The mRNA therapeutics market offers key opportunities in developing vaccines and treatments for chronic and infectious diseases, driven by successful clinical trials and increased government and ...

LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Growth Forecast: What To Expect By 2025? In recent years, the ...

Abstract: In one important chemical engineering unit operation of messenger ribonucleic acid (mRNA) vaccine manufacture, the precious mRNA payload is encapsulated in lipid nanoparticles. Recent ...

Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m ...

CHARLESTON, S.C. (WCSC) - The Trump administration started to cut funding from messenger ribonucleic acid vaccine research earlier this month, impacting more than 20 contracts for vaccine development.

Messenger RNA (mRNA) is a subtype of RNA. An mRNA molecule carries a portion of the DNA code to other parts of the cell for processing. mRNA is created during transcription. During the transcription ...

“Nearly 30 years after Karikó first began her research into modified mRNA, the COVID-19 pandemic brought mRNA vaccines to the center of the scientific world.” On October 2, the Nobel Assembly at ...

CureVac was founded in 2000, and its focus is on developing vaccines and therapies using messenger ribonucleic acid, or mRNA. mRNA offers several advantages, including cell-free, rapid, large-scale ...

CureVac was founded in 2000, and its focus is on developing vaccines and therapies using messenger ribonucleic acid, or mRNA. mRNA offers several advantages, including cell-free, rapid, large-scale ...